Convoke Secures $8.6M to Develop AI Operating System for Biopharma

August 20, 2025
Convoke has raised $8.6 million in seed funding to advance its AI-native operating system for biopharma, aiming to streamline drug development processes.

Convoke Holdings, Inc. has raised $8.6 million in seed funding to develop its AI-native operating system for the biopharma industry, announced in a press release. The funding round was led by Kleiner Perkins and Dimension Capital, with participation from several other investors.

Convoke's platform is designed to transform raw data into actionable deliverables, helping drug developers accelerate the journey from concept to market. The system aims to reduce the time spent on manual and repetitive tasks by automating processes using language model-based systems. This approach is intended to increase efficiency and reduce the development cycle times for new drugs.

The platform serves as an "information factory" for biopharma knowledge work, enabling companies to ingest and structure data, build automations, and generate critical deliverables such as regulatory documents and competitive intelligence briefs. By automating these processes, Convoke allows biopharma teams to focus on strategic decision-making rather than manual workflows, potentially saving significant time and resources.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

08/20
Live Oak Ventures Invests in Cascading AI for Loan Automation
08/20
ChatBlu Secures $500K to Automate E-commerce Inventory
08/20
Datacor Acquires Informetric Systems to Boost Manufacturing Intelligence
08/20
Kasa Secures $40M to Enhance AI-Powered Hospitality System
08/20
Yourway Learning Secures $9 Million for AI in K-12 Education

More from: Life Sciences

08/20
TNO Launches Motion Comfort Institute for Automated Vehicles
08/20
United We Care and Mason County Launch AI-Driven Mental Health Pilot
08/19
LifeKnight Appoints Dr. Thomas Osborne as Lead Advisor for AI Innovation
08/19
HoneyNaps Launches Cloud-Based AI Sleep Diagnostic Tool SOMNUM
08/19
Nerveblox AI Software Gains FDA Clearance for Regional Anesthesia

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like